Holen Sie sich die Stockscreener-App
61.36
5.69%
-3.70
Handel nachbörslich:
61.36
Guardant Health Inc Aktie (GH) Neueste Nachrichten
The Oncology Institute, Inc. shares rise 1.70% intraday after Guardant Health's positive clinical readout update for its Shield™ blood test. - AInvest
Why Guardant Health (GH) Shares Are Plunging Today - FinancialContent
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run - inkl
Guardant Health Updates Results for Shield Blood Test in Colorectal Cancer - MarketScreener
Guardant Health Plunges 11.05% Amid Insider Trading Concerns - AInvest
Guardant drops after trial data for cancer test (GH:NASDAQ) - Seeking Alpha
What drives Guardant Health Inc.’s stock priceJuly 2025 Rallies & Risk Controlled Swing Alerts - khodrobank.com
Guardant Health’s Shield blood test shows 84% sensitivity for colorectal cancer - Investing.com
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test - Yahoo Finance
Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players - openPR.com
When is the best time to exit Guardant Health Inc.Earnings Overview Report & Daily Technical Stock Forecast Reports - Newser
How to read the order book for Guardant Health Inc.July 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
What to do if you’re stuck in Guardant Health Inc.Insider Buying & Fast Gain Stock Trading Tips - Newser
How volatile is Guardant Health Inc. stockPortfolio Risk Summary & Low Risk Investment Opportunities - khodrobank.com
Technical signs of recovery in Guardant Health Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Is it too late to sell Guardant Health Inc.IPO Watch & Advanced Swing Trade Entry Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares - Investing.com
Using flow based indicators on Guardant Health Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares By Investing.com - Investing.com UK
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Top Gainers & Risk Managed Trade Strategies - Newser
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Multi asset correlation models including Guardant Health Inc.Options Play & Daily Profit Focused Stock Screening - Newser
Is Guardant Health Inc. showing signs of accumulationEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Guardant Health Inc. stock daily chart insightsPortfolio Profit Report & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - Eastern Progress
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Will Guardant Health Inc. see short term momentumTrade Volume Summary & Growth Focused Stock Reports - Newser
What’s the analyst consensus on Guardant Health Inc.Rate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
Is Guardant Health Inc. impacted by rising ratesQuarterly Profit Review & Smart Money Movement Alerts - khodrobank.com
Will Guardant Health Inc. bounce back from current supportJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Live market analysis of Guardant Health Inc.Dividend Hike & Stepwise Swing Trade Plans - Newser
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Market Mood & High Yield Stock Recommendations - Newser
Guardant Health Inc. stock prediction for this weekTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Will Guardant Health Inc. Bounce From 52 Week Low getLinesFromResByArray error: size == 0 - 더경남뉴스
Guardant Health Inc. stock outlook for YEARForecast Cut & Expert Curated Trade Setup Alerts - Newser
Will Guardant Health Inc. stock recover after recent drop2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
3.32%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):